Pharmacy - Other

The American Hospital Association released a report last week showing that total drug spending per hospital admission increased 18.5% between FYs 2015 and 2017.
Last week, Sen. Bernie Sanders (I-Vermont), along with several Democratic Senate and House members, including House Oversight Committee Chairman Elijah Cummings (D-Md.), announced the release of three bills intended to lower drug prices.
A U.S. District Court has issued a permanent injunction to CMS, halting the federal government’s nearly 30% reduction in reimbursements to certain hospital outpatient departments purchasing drugs through the 340B program.
Last week, the Centers for Medicare and Medicaid Services responded to the state’s 1115 Medicaid Waiver request that had been filed last September.
The Massachusetts House of Representatives could begin consideration as early as tomorrow on a massive healthcare reform bill.
President Trump signed into law the Right to Try Act of 2017, which will allow terminally ill patients to try certain investigational drugs.
Sen. Elizabeth Warren (D-Mass.) defended the 340B drug program and the hospitals and health centers that rely on it at a hearing last Thursday.
A U.S. District Court dismissed a lawsuit regarding a Medicare policy that would reduce hospital payments under the 340B program.
When CMS issued the final outpatient prospective payment system rule last week it etched into regulation what had only been proposed: significant Medicare reimbursement cuts to hospitals for pharmaceuticals.
When CMS issued the final outpatient prospective payment system rule last week it etched into regulation what had only been proposed: significant Medicare reimbursement cuts to hospitals for pharmaceuticals.
Governor Charlie Baker testified before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) on Thursday, arguing in favor of continuing the cost-sharing reductions that are included in the Affordable Care Act and that help insur
At its Wednesday meeting, the Health Policy Commission (HPC) released data confirming what providers see each day from the opioid crisis in Massachusetts.
A broad coalition of organizations, including MHA, called for passage of legislation to promote transparency in prescription drug prices.
MHA appreciates the opportunity to submit comments in strong support of SB627, “An Act to Promote Transparency in Prescription Drug Prices.

Resources

Click on the links below for easy access to important information related to state healthcare issues and advocacy.
Visit the Commonwealth of Massachusetts websites below to find information on legislative hearings and other meetings of interest to the healthcare community.
To guide your navigation of the legislative process and assist your advocacy efforts, please visit the following state websites:
MHA has also developed the following documents for your information and benefit: